Zybio Creatine Kinase MB (CK-MB) Isoenzyme – Sensitive Cardiac Biomarker Assay

The Zybio Creatine Kinase MB (CK-MB) Isoenzyme test is a clinically validated cardiac biomarker assay designed for accurate measurement of the CK-MB isoenzyme—a key indicator of myocardial injury and acute coronary events. Specifically optimized for use with ZYBIO clinical chemistry and immunoassay analyzers, this reagent delivers fast, reliable, and reproducible results critical to emergency care, cardiology diagnostics, and routine laboratory testing.

Engineered with high specificity and robust quality control, the Zybio CK-MB assay supports precise detection of elevated CK-MB levels in human serum or plasma, helping clinicians assess acute myocardial infarction (AMI), monitor cardiac muscle damage, and guide patient management. Its broad application suitability makes it ideal for hospitals, clinical laboratories, diagnostic centers, and cardiology units.

Key Features

• Sensitive and specific CK-MB isoenzyme detection

• Optimized for ZYBIO chemistry/immunoassay analyzers

• Fast turnaround with high reproducibility

• Stable reagent formulation with consistent performance

• Supports emergency and routine cardiac testing workflows

• Ideal for serum or plasma specimens

Clinical Applications

• Early detection of myocardial infarction (AMI)

• Cardiac risk assessment and monitoring

• Evaluation of cardiac muscle damage

• Emergency and critical care diagnostics

The Zybio Creatine Kinase MB (CK-MB) Isoenzyme assay is a dependable solution for laboratories that require accurate cardiac enzyme measurement, rapid results, and enhanced diagnostic confidence in cardiovascular care.